Literature DB >> 6833789

Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome.

P M Schlievert.   

Abstract

Staphylococcal pyrogenic exotoxin type C (PE-C) suppressed synthesis of IgM antibodies to sheep erythrocytes by in vitro cultures of murine and rabbit splenocytes. Maximal suppression was observed on day 4 of culture and at PE-C doses of 0.1 and 0.01 microgram per 10(7) splenocytes. Endotoxin, added to cell cultures containing PE-C, caused further suppression of IgM synthesis. Endotoxin alone added to cultures was not immunosuppressive. Sublethal doses of PE-C plus endotoxin also suppressed complement-fixing antibody responses in rabbits to sheep erythrocytes; neither agent alone was suppressive. Further, the combination of PE-C and endotoxin blocked reticuloendothelial clearance of colloidal carbon by 50% during a 20-min period. PE-C enhanced the skin reactivity of rabbits previously sensitized to purified protein derivative. One-half of rabbits immunized with PE-C emulsified in adjuvant failed to make antibody to PE-C during a 112-day period. The animals that were nonresponsive to PE-C were able to make antibodies to sheep erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833789     DOI: 10.1093/infdis/147.3.391

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments.

Authors:  C Edwin; E H Kass
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

3.  Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.

Authors:  D H Beezhold; G K Best; P F Bonventre; M Thompson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.

Authors:  B Christensson; P J Johansson; V A Oxelius
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

5.  Effect of toxic shock syndrome toxin 1 on chicken embryos.

Authors:  J C de Azavedo; R N Lucken; J P Arbuthnott
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

6.  Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1.

Authors:  H Fujiwaka; H Igarashi; H Usami; S Tanaka; H Tamura
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 7.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 8.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Toxic shock syndrome: clinical and laboratory findings in 30 patients.

Authors:  A W Chow; C K Wong; A M MacFarlane; K H Bartlett
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

10.  Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.

Authors:  M W Reeves; R J Arko; F W Chandler; N B Bridges
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.